Swertiamarin (P < 0.001) significantly down regulated the candidate genes viz SREBP1c, FAS, ACC-1 and CPT-1 in PCOS-IR as compared to PCOS-NIR where it did not show any effect. The gene discussed is SREBF1; the disease is polycystic ovary syndrome.